Bristol-Myers Squibb Company (BVMF:BMYB34)

Brazil flag Brazil · Delayed Price · Currency is BRL
322.81
+9.72 (3.10%)
At close: Feb 6, 2026
-7.23%
Market Cap658.68B -7.2%
Revenue (ttm)265.45B -0.2%
Net Income38.85B
EPS19.06
Shares Outn/a
PE Ratio16.95
Forward PE9.88
Dividend8.97 (2.78%)
Ex-Dividend DateJan 2, 2026
Volume944
Average Volume71
Open310.28
Previous Close313.09
Day's Range310.28 - 323.04
52-Week Range227.85 - 369.03
Beta0.30
RSI71.79
Earnings DateFeb 5, 2026

About BVMF:BMYB34

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange Brazil Stock Exchange
Ticker Symbol BMYB34
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements